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Abstract
Chromatin-immunoprecipitation (ChIP) employs generally a mild formaldehyde cross-linking step, which is followed by
isolation of specific protein-DNA complexes and subsequent PCR testing, to analyze DNA-protein interactions. Poly(ADP-
ribosyl)ation, a posttranslational modification involved in diverse cellular functions like repair, replication, transcription, and
cell death regulation, is most prominent after DNA damage. Poly(ADP-ribose)polymerase-1 is activated upon binding to
DNA strand-breaks and coordinates repair by recruitment or displacement of proteins. Several proteins involved in different
nuclear pathways are directly modified or contain poly(ADP-ribose)-interaction motifs. Thus, poly(ADP-ribose) regulates
chromatin composition. In immunofluorescence experiments, we noticed artificial polymer-formation after formaldehyde-
fixation of undamaged cells. Therefore, we analyzed if the formaldehyde applied during ChIP also induces poly(ADP-
ribosyl)ation and its impact on chromatin composition. We observed massive polymer-formation in three different ChIP-
protocols tested independent on the cell line. This was due to induction of DNA damage signaling as monitored by cH2AX
formation. To abrogate poly(ADP-ribose) synthesis, we inhibited this enzymatic reaction either pharmacologically or by
increased formaldehyde concentration. Both approaches changed ChIP-efficiency. Additionally, we detected specific
differences in promoter-occupancy of tested transcription factors as well as the in the presence of histone H1 at the
respective sites. In summary, we show here that standard ChIP is flawed by artificial formation of poly(ADP-ribose) and
suppression of this enzymatic activity improves ChIP-efficiency in general. Also, we detected specific changes in promoter-
occupancy dependent on poly(ADP-ribose). By preventing polymer synthesis with the proposed modifications in standard
ChIP protocols it is now possible to analyze the natural chromatin-composition.
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Introduction
The method of chromatin immunoprecipitation (ChIP) is widely
used to monitor changes in chromatin composition. By mild
treatment of cells with formaldehyde, covalent protein-DNA cross-
links are formed. After lysis chromatin is fragmented by sonication
and antibodies are used to precipitate protein-DNA complexes.
Subsequently, DNA is isolated and analyzed by PCR regarding
the presence of specific sequences [1]. We detected in formalde-
hyde-fixed cells the biopolymer poly(ADP-ribose) without the
application of genotoxins. In general, this enzymatic product can
only be observed in cells directly after treatment with DNA
damaging agents, as its abundance in unstressed cells is below
detection limit. Poly(ADP-ribosyl)ation (PARylation) is a post-
translational modification of proteins catalyzed by the family of
poly(ADP-ribose)polymerases (PARPs) [2,3] and consists of
protein-coupled, linear or branched chains of covalently linked
ADP-ribose units synthesized from NAD
+ [4]. PARylation
regulates processes such as transcription [5–11], replication [12],
vesicle trafficking [13], telomere maintenance [14,15], mitosis
[16–19], cell death [20] and chromatin organization [21–29], but
most prominent is this enzymatic reaction in DNA repair [30].
Binding to DNA single-strand and double-strand breaks as
induced by genotoxins or during replication stimulates the
enzymatic activity of PARP1 and PARP2. Main acceptors of
PARylation are histones and PARPs themselves, but many more
proteins have been described as targets. While some acceptor
proteins are covalently modified by PAR, a large number of
proteins interact with PAR non-covalently [31–34], and in either
case, protein function is altered. Covalent modification inactivates
the acceptor in general, whereas the effect of non-covalently
bound PAR can be diverse. For example, the base-excision repair
platform protein XRCC1 is attracted by PAR to damaged sites
[35], whereas nucleosomes are disassembled due to the high
affinity of histones to PAR [36], thus opening up chromatin.
Macro-domain containing proteins like the histone variant
macroH2A [29] and the chromatin remodeler Alc1 [27] can bind
poly(ADP-ribose) in a capping like fashion and accumulate at sites
of PAR synthesis. Additional PAR binding motifs are a PAR-
binding Zinc-finger (PBZ) [33] and a conserved sequence of basic
and hydrophobic amino acids [31]. Next to the regulation of base-
excision repair, PAR is necessary for full activation of ATM [37]
and recruitment of signal transmission factors [38]. As damage-
dependent PAR formation is crucial for single-strand break and
base-excision repair, PARP inhibition is applied in tumor therapy
[39,40].
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32914Here we show that formaldehyde commonly used as fixative in
ChIP methods induces strand breaks and massive PAR synthesis,
altering ChIP results. Changing the protocol by adding PARP
inhibitors or using a more stringent fixation regimen prevents this
PARylation and alters not only the amount of proteins cross-linked
to DNA, but also relative promoter occupancies. Our data provide
evidence that standard ChIP procedures are flawed by induction
of PAR formation, which changes chromatin composition.
Therefore, data obtained with conventional chromatin-immuno-
precipitation protocols have to be interpreted with caution.
Results
The presence of poly(ADP-ribose) in cells is in general below
detection limit in immunofluorescence studies without genotoxic
treatment. To observe PAR formation after application of DNA-
damaging agents, standard fixation protocols include either
alcohol (methanol or ethanol) or 10% trichloroacetic acid. If
formaldehyde is used as a fixative similar to experiments aiming at
protein localization, we often noticed false positive PAR signals in
control cells not exposed to genotoxins. In order to analyze this
finding more closely, we used different concentrations of
formaldehyde ranging from 0.2% to 10% and varying fixation
times between 5 to 20 min (Figure 1A). Our data reveal that under
these conditions PAR formation in HeLaS3 cells occurs indepen-
dently of genotoxic treatment and is inversely correlated to
formaldehyde concentration and duration of fixation, i.e. high
formaldehyde concentrations reduce the time necessary to quench
polymer production. 5 min of 2% formaldehyde resulted in only
50% PAR-positive cells, with a decrease down to 0% at 20 min.
Using 3.7% formaldehyde, 10 min incubation time was already
sufficient to completely suppress PAR formation (Figure 1B).
Having established the link between PARP activity and low-
dose formaldehyde fixation, we focused on the technique of
chromatin immunoprecipitation (ChIP). In this method, a
10 minute/1% formaldehyde fixation step is typically used to
crosslink proteins with DNA. We analyzed three different
published ChIP protocols abbreviated JLI, MLI and UMC,
respectively [41–43] and tested them for induction of PAR
formation (Figure 2A). As summarized in Fig. 2B, nearly 100% of
the cells were polymer positive in all three protocols, whereas
standard methanol fixation showed no signal. To exclude that
PAR formation is confined to HeLa cells and to define, which
PARP is the prevalent enzyme performing this reaction, we
employed mouse 3T3 fibroblasts and subjected them to JLI
fixation procedure (Figure 2C). Wild type (wt) cells also showed
massive PAR synthesis with formaldehyde, similar to HeLa cells.
Genetic deletion of either PARP1 protein (P1ko) or PARP2
protein (P2ko) reduced PAR levels to a similar extent of about
40%, which suggests that at least these two PARPs are responsible
for synthesis of polymer after low-dose formaldehyde treatment. In
order to abrogate PAR synthesis, we used the standard treatment
to suppress polymer production after DNA damage by applying
2 mM PJ34, a pan-PARP inhibitor, 6 h in advance of fixation
(Figure 3). Still, we observed polymer signals in all cells after
formaldehyde fixation. In order to determine at which point of the
JLI protocol [42] PAR is produced, we fixed the cells with
methanol directly after the formaldehyde or the PBS washing step,
respectively. Only methanol application directly after formalde-
hyde fixation reduced PAR formation significantly. Therefore,
PARP activity is triggered during formaldehyde incubation and
aggravated during PBS washings, as PAR intensity is massively
increased. This enzymatic reaction could only be blocked by a
combined pre- and post-incubation with the inhibitor (Figure 3A,
panel VII). This suggests that the fixation process itself induces
PARP activity.
In the next step, we investigated if formaldehyde fixation
induces DNA damage and related signaling by analyzing cH2AX
formation with confocal microscopy. We detected a more than
sevenfold increase in cells with high amounts of cH2AX foci if
treated with 1% formaldehyde compared to 4% formaldehyde,
reflecting massively induced DNA strand-break signaling
(Figure 4A). The overall cH2AX intensity in the whole nucleus
increased eightfold (Figure 4B). Co-localization analysis in HeLa
Figure 1. Low formaldehyde concentration and short fixation induce PAR formation. (A) HeLaS3 cells were fixed with increasing
formaldehyde concentrations and for indicated times. Formaldehyde concentrations are indicated on the left side, fixation time on top.
DAPI=nucleus; PAR=poly(ADP-ribose). Scale bars represent 10 mM. (B) Evaluation of three independent experiments (N=3) with at least 50 cells per
N as in (A) including 10% formaldehyde (FA) values. Increasing fixation time using 2% FA and 3.7% FA leads to significant decrease in PAR formation.
Means were compared to the respective 5 min value. Error bar represent mean6s.e.m., **P,0.01; data were analyzed with one-way ANOVA and
Dunnett’s Multiple Comparison Test.
doi:10.1371/journal.pone.0032914.g001
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both DNA damage markers work independently (Figure S1A–D,
see Materials and Methods S1 for experimental setup), with very
low if any overlap. Additionally, short term PJ34 application
before fixation suppressed synthesis of PAR, but not of cH2AX
foci, whereas 3.7% formaldehyde abrogated appearance of both
DNA damage markers (Figure S1A–B). Thus, PARP activity
seems to be induced by the formation of different DNA lesions
than cH2AX, but both signaling processes are abrogated at high
concentrations of formaldehyde.
In order to determine the impact of formaldehyde-induced
PARP activity on ChIP efficiency, we designed two modified
versions of a common ChIP method on the basis of the JLI
protocol. We compared the original protocol with one including
2 mM of the PARP inhibitor PJ34 in all steps until lysis (PJ34),
starting from 6 h ahead of sample processing as the only variation.
Another modification was fixation for 10 min with 3.7%
formaldehyde (BMB) instead of 1%. In order to obtain in this
case comparable results for chromatin fragmentation, sonication
cycles had to be increased two- to fourfold to achieve a similar
pattern in DNA fragment length. Otherwise, treatment was
identical to standard JLI protocol. To test our hypothesis that
formaldehyde fixation alters ChIP efficiency, we probed in initial
ChIP experiments for binding of PARP1 to the autoregulatory site
in the PARP1 promoter (Figure 5). A weak hairpin structure is
stabilized by PARP1 binding [44], leading to transcriptional
repression [45]. Therefore, if DNA-binding of PARP1 is
compromised by automodification, this would be reflected by a
reduced degree of PARP1 binding to the hairpin without
suppression of PARylation. We immunoprecipitated PARP1 using
the three different protocol variants (JLI/PJ34/BMB). Isolated
DNA from input samples or recovered from immunoprecipitation
was tested by semi-quantitative PCR for the presence of the
promoter sequence. By comparing the PCR product signal
intensities we detected a significant increase (1.7fold and 2.1fold
for PJ34 and BMB, respectively) in ChIP efficiency if PARP
activity was inhibited by PJ34 or by the more stringent fixation
procedure. As control, we immunoprecipitated all samples with an
irrelevant monoclonal antibody (12F10) and tested these in PCR.
None of them yielded any detectable amplification products, thus
demonstrating specificity of the precipitation. These experiments
proved that PARylation affects protein binding to DNA at least in
the case of PARP1. To further analyze the impact of PARylation
on ChIP efficiency, we chose other transcription factors as well as
histone H1 as a reported high-affinity binder to PAR [46], and
tested their presence at published binding sites (Table S1) using
the JLI and BMB protocols in parallel.
Suppressing PARylation increased significantly ChIP efficiency
in general, but affected specific promoters selectively (Figure 6A).
Most prominently, ChIP efficiency was increased more than
twofold at the H19_ICR imprinting control region, already known
to be sensitive to the presence of PAR [47], but PARylation did
Figure 2. Fixation by ChIP protocols induces PARylation.( A) PAR staining after fixation by three different ChIP protocols or methanol. ChIP
fixations induce PAR staining (I–III). Methanol fixation shows no PAR formation (IV). H2O2 and methanol fixation (V) induces granular PAR staining.
Focal PAR formation in JLI fixation (I) is reverted to normal distribution if H2O2 is applied in advance (VI). Procedures are indicated below microscopic
pictures. Scale bars represent 10 mM. (B) Statistical evaluation of data obtained in (A). Three independent experiments (N=3) were analyzed with at
least 50 cells each data point of one experiment. % PAR positive cells were calculated and analyzed by one-way ANOVA and Bonferroni’s Multiple
Comparison Test; ***P,0.001. Only methanol fixation is significantly different from the others. Error bars represent mean6s.e.m. (C) Mouse 3T3 cells
were fixed by JLI protocol. PAR formation was detected in all three lines tested, i.e. wild type (wt), PARP1 knockout (P1ko) and PARP2 knockout (P2ko).
PAR-fluorescence intensities of cells from four randomly chosen microscopic fields per cell line were analyzed by ImageJ and normalized to intensity
in wt cells (RFU: relative fluorescence units). At least six independent experiments were used for statistical analysis by One-Way-ANOVA with
Bonferroni’s Multiple Comparisons Test; error bars represent mean6s.e.m. (N$6), ***P,0.001 wt vs. P1ko, ****P,0.0001 wt vs. P2ko, P1ko vs. P2ko
not significant.
doi:10.1371/journal.pone.0032914.g002
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e32914Figure 3. PARP inhibition suppresses PAR formation only if present in every step. (A) Detection of PAR by immunofluorescence after
different fixation strategies. H2O2 in combination with methanol fixation induces an even distribution of PAR-staining within the nucleus (I).
Pretreatment of cells with 2 mM PJ34 6 h in advance of damage induction and methanol fixation completely suppresses PAR formation (II). Fixation of
cells with JLI protocol induces polymer synthesis without H2O2 (III), but in contrast to (II), PJ34 is not able to block PARP activity completely (IV).
Methanol fixation directly after the formaldehyde step reduces PAR staining (V), but not if the cells were fixed after PBS washing (VI). PJ34 is able to
suppress PAR formation only if present in all steps until lysis (VII). Scale bars represent 10 mM. (B) Flow chart of the different fixation strategies.
Standard JLI fixation (III) encompasses all steps until lysis/permeabilization for immunofluorescence detection. Preincubation with 2 mM PARP
inhibitor PJ34 (IV) is otherwise identical to (III). Methanol is used to fix cells either directly after formaldehyde treatment (V), or after PBS washes (VI).
(VII) 2 mM PJ34 is used for preincubation and continuous treatment of cells during all steps until lysis/permeabilization for immunofluorescence
detection.
doi:10.1371/journal.pone.0032914.g003
Figure 4. Low-dose formaldehyde induces cH2AX formation. Cells were fixed with 1% or 4% paraformaldehyde and analyzed by confocal
microscopy. (A) cH2AX foci were counted using one confocal slice after reducing background staining by ImageJ software. Reduction parameters
were identical for respective pictures. Cells were split into three groups with (i) less than 5, (ii) between 5 and 20, (iii) more than 20 foci, and percent of
total cells was calculated. 10 min 1% paraformaldehyde (1% FA) induces more than sevenfold increase in cells with more than 20 foci, and a decrease
in cells with less than 5 foci compared to 4% paraformaldehyde (4% FA). Error bars represent mean6s.e.m. (N=3), ***P,0.001; data were analyzed
with one-way ANOVA and Dunnett’s Multiple Comparison Test. (B) All pictures from a z-stack were analyzed for cH2AX foci intensity and normalized
to cells fixed for 20 min with 4% paraformaldehyde. Intensity increases eightfold with 1% FA compared to 4% FA. Error bars represent mean6s.e.m.
(N=3), *P=0.016; data were analyzed by unpaired t-test.
doi:10.1371/journal.pone.0032914.g004
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protein CTCF to the BRCA1 promoter. Binding of E2F1 to sites in
4 different promoters was significantly increased, similar to
binding of NFkB (subunit RELA) to HIF1A and MYC promoters
and NFYB to the TOP2A promoter. Interestingly, comparing
ChIP efficiencies between transcription factors and H1 at the same
site showed in some cases an opposite behavior (compare
Figure 6A and 6B). Prominent examples are again the CTCF
binding sites: Whereas suppression of polymer synthesis increased
occupancy of CTCF at the H19_ICR locus, H1 binding was not
altered, and at the BRCA1 promoter regulation was inverse, as
PARylation affected significantly H1 binding, but not CTCF. In
order to exclude any influence of formaldehyde concentration on
efficiency of the subsequent PCR reaction, we analyzed input
fragment intensities after PCR. In no case a significant change in
PCR efficiency was detected except for the NFkB site in the
HIF1A promoter (Figure 6C). To exclude chromatin alterations
induced by prolonged incubation with PARP inhibitors and to
control for possible changes due to increased formaldehyde
concentrations at different sites, we performed additional exper-
iments using two pairs of antibodies with respective promoter
sequences, i.e. CTCF with BRCA1 promoter or H19-ICR, and
NFkB with MYC or HIF1A (see Materials and Methods S1 for
experimental setup). In this set, PJ34 was added immediately
before application of 1% formaldehyde (JLI protocol) instead of
the overnight incubation and compared to chromatin fixed with
standard JLI procedure in parallel. As summarized in Figure S2,
short-term incubation with PJ34 led to similar results regarding
PAR suppression and ChIP efficiency as fixation with 3.7%
formaldehyde. These data support our findings that standard
fixation procedures employing 1% formaldehyde (or even less)
artificially induce poly(ADP-ribosyl)ation and chromatin alter-
ations, which can be abrogated by suppressing PAR formation,
either by PARP inhibition or fixation with 3.7% formaldehyde.
In summary, our data demonstrate that suppressing PAR
production during ChIP fixation significantly impacts on the
results obtained by this method. Therefore, we suggest in future
ChIP experiments either the use of PARP inhibitors or 3.7%
formaldehyde as fixative to avoid induction of PARylation and
resulting artifacts.
Discussion
PARP activity has been implicated in many processes within a
cell, and most of them are connected to genomic maintenance and
fidelity[3].Theserequiretheremodulationofchromatin,i.e.during
DNA repair, replication, telomere maintenance and transcription.
Most recently, PARP1 has been shown to regulate specifically the
expression of nuclear encoded genes involved in mitochondrial
DNA repair [48]. PARPs have been shown to take part in all the
above mentioned pathways, but most prominent is the enzymatic
activity stimulated by DNA strand breaks. We show here that
fixation of cells with low doses of formaldehyde also induces DNA
damage signaling and PARylation (Figures 1, 2, 3) in human and
mouse cell lines. The dose- and time-dependent decline in cellular
PARylation during formaldehyde treatment relies most likely on
successive inactivation of the enzyme by formaldehyde (Figure 1).
Synthesisofpoly(ADP-ribose)is mainlyinducedduringthewashing
step after crosslinking in ChIP experiments (Figure 3). Using
fibroblasts from different PARP knockout strains (Figure 2C), we
determined PARP1 and PARP2 as independent sources of
poly(ADP-ribose), but it could well be that also other putatively
DNA-dependent PARPs like PARP3 [49] are activated by mild
formaldehyde treatment. We could show that polymer formation is
associated with a reduced ChIP-efficiency compared to two
modified protocols in which we suppressed PAR synthesis. Testing
for the autoregulatory site in the PARP1 promoter (Fig. 5), we
achieved a twofold improvement of ChIP-efficiency by increasing
formaldehyde concentration in the fixation step to 3.7%. Suppres-
sionofPARPactivitybyinhibitortreatmentwasslightlylesseffective
(1.7fold), but still yielded significantly more product in semi-
quantitative PCR than the original protocol (JLI). The reduced
increase can be explained by the fact that PJ34 is a competitive
inhibitorofNAD
+substratebinding,whichmaystillleadtolowand
undetectable polymer synthesis, but nevertheless subtle changes in
chromatin composition. Alternatively, as cH2AX formation is still
observable after PJ34 application but abrogated by 3.7% formal-
dehydefixation(Figure S1),thisDNAdamagemarkermayalsolead
to changes in the respective protein-DNA interactions, but only to a
minorextent.OurresultsadditionallyshowthatbothDNAdamage
markers, i.e. PAR and cH2AX, are induced by lesions of different
quality, as there is little if any colocalization between them
(Figure S1). Most likely, as PARPs are involved in regulation of
base-excision repair, whereas cH2AX is a well-known marker of
DNA double-strand breaks, PAR is synthesized at single-strand
breaks and cH2AX foci appear at double-strand breaks. In
summary, these data prove that chromatin composition is changed
by the application of standard ChIP procedures per se. In order to
test this in more detail we analyzed several transcription factors as
well as histone H1 for presence at known binding sites. Our data
revealed that - despite a general increase in ChIP efficiency - the
effectofpolymeronbindingofproteinstoDNAstronglydependson
the specific site, and that the change in occupancy of the
transcription factor or histone H1 can be inverse (Figure 6) as most
evident in experiments utilizing the CTCF protein. Even only short
pre-incubationwithPJ34hadaverysimilareffectonChIPefficiency
(Figure S2). Thus, inhibition of PARylation leads not in all cases to
increased ChIP efficiency, pointing to a specific regulation. PARP
activity has been reported recently to rapidly recruit factors
containing macro-domains like macroH2A [27] or Alc1 [29], and
thePAR-dependentrelocalizationofXRCC1toDNAstrandbreaks
has long been known [35]. The attraction of proteins to sites of
polymer production could lead to artificial crosslinking of these to
DNA, yielding false positive results. On the other hand, dislodging
proteins from DNA like histones or p53 [50] upon covalent
modification would give no or not the correct amount of
amplification product in PCR, thus underestimating the binding
ofaspecificprotein,whichwehaveshownnowforseveralimportant
proteins used in ChIP applications. One might speculate that an
important function of PARylation is the modulation of transcrip-
tional activity at promoters after genotoxic stress in regard of fine-
Figure 5. Suppression of PARylation impacts on ChIP efficien-
cy. Evaluation of ChIP efficiency of PARP1 bound to PARP1 promoter.
Both modifications improve significantly ChIP efficiency. Error bars
represent mean6s.e.m. (N=3), *P,0.05, **P,0.01; data were analyzed
with one-way ANOVA and Bonferroni’s Multiple Comparison Test.
doi:10.1371/journal.pone.0032914.g005
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e32914Figure 6. PARylation affects binding of transcription factors and histone H1 differently dependent on the binding site. Preparation of
chromatin and ChIP was done by JLI and BMB protocol, respectively. Three independent chromatin preparations were analyzed by three independent
PCRs each (panels A, C), or by only one PCR each (panel B) due to lack of material. (A) Suppression of PARylation improves ChIP efficiency in general,
but with some specificity. Column color code: blue: ChIP with anti-CTCF antibody; white: ChIP with anti-E2F1 antibody; green: ChIP with anti-p65/
RELA (NFkB) antibody; black: ChIP with anti-NFYB antibody. Respective binding sites and promoters are indicated on Y-axis of panel C. J=JLI
protocol; B=BMB protocol. Error bars represent mean6s.e.m. (N=3), exact P-values are indicated; data were analyzed by unpaired t-test. Note that
CTCF binding is affected by PARylation at the H19_ICR locus, but not at the BRCA1 promoter. (B) PARylation impacts on histone H1 binding
independent of transcription factors. ChIP was performed with anti-H1 antibody and analyzed for binding at the same positions as in (A). Respective
binding sites and promoters are indicated on Y-axis of panel C. Coding was maintained to simplify comparison. Error bars represent mean6s.e.m.
(N=3), exact P-values are indicated; data were analyzed by unpaired t-test. Note that H1 binding at the CTCF sites is oppositely affected by
PARylation. (C) Increased formaldehyde concentration during fixation does not impact on PCR efficiency. Product signal intensities from input PCRs
were compared. Respective binding sites and promoters are indicated on Y-axis. J=JLI protocol, B=BMB protocol. Coding was maintained to simplify
comparison between panels. Only NFkB/RELA binding to HIF1A promoter displayed border-line significance in PCR efficiency. Error bars represent
mean6s.e.m. (N=3), *P=0.045; data were analyzed by unpaired t-test.
doi:10.1371/journal.pone.0032914.g006
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e32914tuning transcription factor binding, as we mostly detected a mild
two- to threefold enhancement in ChIP efficiency except for NFkB
binding to the HIF1A promoter, which was increased nearly
sevenfold.Figure7depictsourworkingmodelforPARPsuppression
in ChIP.
In summary, our results prove that standard ChIP protocols
lead to artificial PAR production. As PAR changes chromatin
organization by interaction with histones and transcription factors,
this drastically influences the results of ChIP experiments. We
show that inhibition of PARP either by PJ34 or by 3.7%
formaldehyde is beneficial in maintaining the in vivo composition
of chromatin, as both regimens prevent PARP activation. Our
ChIP data reveal that this is in general associated with increased
ChIP efficiency, and that comparing results obtained with the new
and the old method can be utilized to uncover transcription factor
binding sites that are especially sensitive or insensitive to
poly(ADP-ribosyl)ation.
Deduced from our findings, previous data obtained by
chromatin-immunoprecipitation have to be interpreted with
caution, as they have been flawed by artificial PAR formation. In
order to avoid non-physiological results caused by fixation artifacts
by low formaldehyde concentration, increasing the formaldehyde
concentration in the cross-linking step to 3.7% or including a
PARP inhibitor is strongly recommended.
Materials and Methods
Ethics Statement
N/A
Chemicals
Standard chemicals were purchased either from Sigma Aldrich
(Munich, Germany) or from Merck (Darmstadt, Germany).
Cell culture
HeLaS3 cells (DSMZ, Braunschweig, Germany) and mouse
3T3 fibroblast strains [51–53] were maintained in DMEM
(Invitrogen, Darmstadt, Germany) with 10% fetal bovine serum
(Biochrom, Berlin, Germany) and 1% penicillin/streptomycin
(Invitrogen, Darmstadt, Germany) at 37uC/5% CO2. For long-
term PARP inhibition, 2 mM PJ34 (Enzo Life Sciences, Lausen,
Switzerland) was added to the cell culture medium at least 6 h in
advance of subsequent processing.
Immunostaining and fluorescence microscopy
Cells were seeded on glass cover slips and grown overnight. The
next day, cells were treated with or without 1 mM H2O2 for 7 min
at 37uC and fixed either with 100% methanol for 7 min at 4uC,
with formaldehyde at varying concentrations and time periods as
indicated, with formaldehyde and subsequent 100% methanol
fixation to monitor PAR formation, or by standard ChIP
protocols, respectively. After methanol fixation, cells were rinsed
thrice with Tris-buffered saline (TBS) and stored in TBS for
subsequent immunostaining. Formaldehyde fixation was stopped
by addition of 0.1 M glycine/TBS at room temperature (RT) for
5 min, followed by 2x 3 min washing in TBS at RT. Cells were
permeabilized with 0.4% Triton X-100 in TBS, followed by 2x
3 min washing in TBS at RT.
Cover slips were blocked in TBS/0.2% Tween20/1% BSA
(TTB) at 30uC for 30 min, followed by incubation with primary
antibody 10H [54] against poly(ADP-ribose) in blocking solution
(1:300). After 3 washes with TBS/0.2% Tween20 for 5 min at RT,
secondary antibodies were applied, diluted 1:500 in TTB for goat-
anti-mouse Alexa546 and Alexa488, respectively (Molecular
Probes/Invitrogen, Darmstadt, Germany) and incubated as above.
Cover slips were washed again, incubated for 5 min at RT with
40 ng/ml 49,69-diamidino-2-phenylindole (DAPI, Sigma) and
mounted on glass slides with AquaPolyMount (PolySciences,
Eppelheim, Germany).
For cH2AX staining, cells were fixed with formaldehyde as
above, followed by two washes in PBS and one in 50 mM NH4Cl
in PBS for 10 min each. Cells were permeabilized with 0.2%
TritonX-100 in PBS for 4 min at room temperature. After
extensive washings with PBS, coverslips were incubated with 1%
BSA in PBS for 30 min and then with anti-phosphoH2AX
(Ser139, Millipore, Schwalbach, Germany) antibody diluted 1:500
in PBS containing 10% normal goat serum for 1 h at RT. Alexa
Fluor 546-conjugated goat anti-mouse antibody was used as
secondary antibodies at a dilution of 1:400. cH2AX-positive foci
were visualized by laser scanning confocal microscopy with
identical settings between experiments, and average intensity
projections of 26 z planes of at least 100 nuclei/sample were
measured. Standard immunofluorescence analyses were per-
formed on a Zeiss Axiovert 200M mounted with 40x Plan-
Neofluar (1.3NA) oil objective. Pictures were taken with Zeiss
AxioCam MRm and Zeiss AxioVision4.5 software (Carl Zeiss
Company, Go ¨ttingen, Germany). For confocal microscopy a Zeiss
Laser Scanning Microscope LSM 510 Meta with 63x Plan-
Apochromat (1.4NA) oil objective, Zeiss AxioCam MRm and Zen
software was used. Samples were analyzed in 0.32 mm sections.
Subsequent data processing was done with ImageJ 1.42q
(MacBiophotonics) and Adobe Photoshop.
Figure 7. Model of PAR-dependent chromatin remodeling
during ChIP fixation. On the left side, standard ChIP protocol leads
to PARP (brown) activation and subsequent poly(ADP-ribose) formation
(orange lines) by damaging DNA (red asterisk). This either dislodges
proteins (blue, X) from DNA or attracts proteins (green, Y) to DNA with
subsequent crosslinking (red arc). Therefore, after lysis and sonication,
immunoprecipitated proteins can be present either in wrong amounts
(reduced efficiency), or proteins are crosslinked that are not present on
DNA in physiological conditions (false positive). On the right side, using
3.7% formaldehyde for 10 min as fixation protocol or treatment with
the PARP inhibitor PJ34 throughout the experiment until lysis abolishes
PAR formation completely. Thus, chromatin composition is unaltered
and reflects in vivo situation.
doi:10.1371/journal.pone.0032914.g007
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JLI [42]. 10% crosslinking mix (11% formaldehyde/100 mM
NaCl/ 0.5 mM EGTA/50 mM HEPES, pH8.0) was added to
medium. After 10 min at room temperature, 10% 1.25 M glycine
was added. After removing of the solution, plates were washed 2x
with PBS (3 min each).
For immunofluorescence, PBS was aspirated and replaced by
0.4% TritonX100 in PBS for 5 min at room temperature for
permeabilization. Cover slips were again washed 2x with PBS and
blocked afterwards with blocking solution, followed by immuno-
staining procedure.
To yield chromatin suspension, cells were scraped in 1 ml lysis
buffer (1% SDS/10mM EDTA, pH 8.0/50mM Tris-HCl, pH
8.0/1x complete protease inhibitor mix, Roche) after incubation
for 5 min at 4uC. Suspensions were sonicated on ice for 10 sec at
50% output, with 2 min refractory period (Bandelin Sonoplus
HD-070, tip MS73; Bandelin, Berlin, Germany). Concentration
was adjusted to 1 mg/ml with lysis buffer and stored at 4uC.
For ChIP, suspensions were brought to room temperature and
420 ml were spun down for 5 min at maximum speed. 400 ml
supernatant was mixed with 3.6 ml dilution buffer (1% Triton X-
100/150mM NaCl/2mM EDTA, pH 8.0/20mM Tris-HCl, pH
8.0/1x complete protease inhibitor mix, Roche) and incubated
with by distributor recommended amount of antibody (if no
information available: 1 mg/ml final concentration). Samples were
rotated over night at 4uC. 100 ml of on agarose-beads immobilized
Protein G (ThermoScientific, Rockford/IL, USA) were resus-
pended in 1 ml 9:1 dilution buffer:lysis buffer mix (DB:LB) and
pre-absorbed with 100 mg/ml BSA and 500 mg/ml sheared
salmon sperm DNA overnight at 4uC on a rotator. On the next
day, beads were washed twice with DB:LB and resuspended in 1
ml DB:LB. 100 ml of the beads suspension was added to each cell
lysate and incubated for at least 2 h at 4uC on a rotator.
Suspensions were spun down at 1000 g and supernatant was
aspirated. Beads were washed 3x in 1 ml wash buffer (1% Triton
X-100/0.1% SDS/150 mM NaCl/2 mM EDTA, pH 8.0/
20 mM Tris-HCl, pH 8.0/1x complete protease inhibitor mix;
Roche, Grenzach, Germany) and centrifuged as above. Beads
were washed 1x in 1 ml final wash (1% Triton X-100/0.1% SDS/
500 mM NaCl/2 mM EDTA, pH 8.0/20 mM Tris-HCl, pH 8.0/
1x complete protease inhibitor mix, Roche) and immune-
complexes were eluted by addition of 450 ml elution buffer (1%
SDS/100 mM NaHCO3) 5 min at room temperature. 500 mg/ml
ProteinaseK and RNaseA were added to each sample and
incubated for additional 30 min at 37uC. Cross-linking was
reversed by adding NaCl to a final concentration of 200 mM
and incubation overnight at 65uC. Suspension was spun down and
DNA from the supernatant was isolated by Phenol/Chloroform
procedure and subsequent ethanol precipitation.
MLI [41]. For immunofluorescence, cells on cover slips were
washed once with PBS and solution was replaced with 1%
formaldehyde in PBS. Cells were incubated at room temperature
for 10 min and reaction was stopped by adding 1.25 M glycine to
a final concentration of 0.11 M. Cells were washed 2x with ice
cold PBS and permeabilized by 5 min in 0.4% TritonX100 in PBS
at room temperature. Cover slips were again washed 2x with PBS
and blocked afterwards with blocking solution, followed by
immunostaining procedure.
UMC [43]. Cells on cover slips were fixed by adding
formaldehyde directly to the growth medium to a final
concentration of 1% and incubation for 10 min at 37uC.
Reaction was stopped by adding glycine to a final concentration
of 125 mM and incubation for 5 min at 37uC. Cover slips were
rinsed twice with ice-cold 1x PBS/0.5 mM EDTA and incubated
for 5 min at room temperature with 0.4% TritonX100 to
permeabilize cells. Cover slips were again washed 2x with PBS
and blocked afterwards with blocking solution, followed by
immunostaining procedure.
Chromatin immunoprecipitation protocols variations
Protocols from three different public available sources were used
in this study. See Materials and Methods for detailed protocols:
JLI [42]; MLI [41]; UMC [43].
Variations of JLI protocol. PJ34: 2 mM of PARP inhibitor
PJ34 was included in all protocol steps until lysis.
BMB: Cells were incubated for 10 min with 3.7% formaldehyde
instead of 1% as in JLI. Therefore, number of sonication cycles
had to be increased two- to fourfold in order to achieve similar
fragment sizes of genomic DNA.
Antibodies were purchased from Active Motif (CTCF, E2F1;
Carlsbad/CA, USA) and Santa Cruz Biotechnologies (H1, NFkB
p65/RELA, NFYB; Heidelberg, Germany). CII10 and 12F10
were kind gifts of G.G. Poirier (Quebec/Canada) and W.
Bodemer (Go ¨ttingen/Germany), respectively.
Polymerase chain reaction after chromatin-
immunoprecipitation
PARP1 promoter. 25 ng of input DNA was amplified in
comparison to 1 ml of ChIP-sample by PCR with KOD HotStart
polymerase according to manufacturer’s instructions (Novagen/
Merck, Darmstadt, Germany). PCR was performed in 33 cycles
(20 s 95uC/10 s 59uC/5 s 70uC) and products were resolved on
5% polyacrylamide gels.
Other promoters. For input, lysed material was directly
subjected to PCR amplification. ChIP amplification was
performed similar as above in 35 cycles (20 s 95uC/10 s
annealing temperature/5 s 70uC). Fragments were resolved by
2.5% agarose gel electrophoresis.
Primer sequences and respective annealing temperatures are
listed in Table S1.
Evaluation of ChIP efficiency by PCR
Three independent ChIP experiments were analyzed by three
subsequent PCRs each and averages were compared (N=3). For
H1, each ChIP was followed by only one subsequent PCR due to
lack of material. Fragment signal intensities of input and ChIP
PCRs were analyzed by Fuji-LAS1000 and Aida3.1 software (Fuji,
Du ¨sseldorf, Germany).
Statistical evaluation
Samples were analyzed with GraphPad software Prism5 or
Instat3 (GraphPad, La Jolla/CA, USA). Statistical tests used are
indicated in the respective figure legends. A P-value ,0.05 was
considered significant, and exact P-values are reported if possible.
Supporting Information
Figure S1 (A) PAR and cH2AX staining in HeLa cells and
human VH7 fibroblasts after JLI and BMB fixation. Human
tumor (HeLa S3) and normal (VH7 fibroblast) cells were fixed by
JLI (1% FA) or BMB (3.7% FA) protocol and analyzed for
appearance of PAR and cH2AX foci. Whereas 1% FA clearly
induces PAR as well as cH2AX, both DNA damage markers are
abolished (VH7) or greatly diminished (HeLa S3) if 3.7% FA is
used for fixation. (B) PAR and cH2AX staining in HeLa cells and
human VH7 fibroblasts after JLI and JLI+PJ34 fixation. Human
cells were fixed by JLI (1% FA) or JLI+PJ34 protocol and analyzed
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e32914for appearance of PAR and cH2AX foci. Whereas 1% FA clearly
induces both PAR and cH2AX, simultaneous PJ34 application
abolishes PAR synthesis in tumor (HeLa) and normal (VH7) cells,
but has no impact on suppressing cH2AX formation. (C) PAR and
cH2AX are markers of DNA lesions of different quality. HeLa
cells were fixed by JLI protocol and immunostained for PAR
(green) and cH2AX (red). Cells were analyzed for colocalization of
PAR and cH2AX foci using ImageJ software. As evident from the
respective Pearson’s analysis (data in lower panel), foci show some,
but only low degree of colocalization of both DNA damage
markers after JLI fixation. As there is no PAR synthesis after PJ34
treatment, there is also no colocalization detectable. For better
visualization, fluorescence intensities along a track line were
analyzed. (D) PAR and cH2AX are markers of DNA lesions of
different quality. VH7 cells were fixed by JLI protocol and
immunostained for PAR (green) and cH2AX (red). Cells were
analyzed for colocalization of PAR and cH2AX foci using ImageJ
software. In the upper panel the image of a segmented nucleus and
the corresponding scatter plot and correlation coefficients are
shown. As evident from Pearson’s analysis, foci show no
colocalization of both DNA damage markers after JLI fixation.
For better visualization of foci distribution, the lower panel
displays the fluorescence intensities of green and red along the
indicated track line. As there is no PAR synthesis after PJ34
treatment or 3.7% formaldehyde, colocalization analysis was not
performed.
(PDF)
Figure S2 Application of PJ34 immediately before JLI
fixation is similar to fixation with BMB protocol in ChIP
efficiency. HeLa cells were fixed by JLI protocol with 10 mM
PJ34 application immediately before fixation. Chromatin was
immunoprecipitated as indicated by CTCF or NFkB antibody as
described. Precipitates were analyzed by PCR for the same DNA
sequences as tested in Figure 6. Three independent chromatin
preparations for each fixation were analyzed in parallel by one IP
followed by one PCR. Intensity from an unspecific ChIP-PCR was
subtracted from specific ChIP-PCR intensity and results were
normalized to input-PCR intensity. Data from respective samples
analyzed in parallel were subjected to two-tailed paired t-test.
Actual P-values are indicated. Figure S2A shows results for CTCF
antibody ChIP at BRCA1 promoter and H19_ICR region,
Figure S2B for NFkB antibody ChIP at MYC and HIF1A
promoters.
(TIF)
Materials and Methods S1 Immunofluorescence analy-
sis and modified ChIP procedure for experiments
described in Supporting Information. Colocalization anal-
ysis between PAR and cH2AX was performed according to [55].
(DOC)
Table S1 Promoters and regions tested by ChIP for
binding of denoted proteins, amplicon position and
primer sequences.
(DOC)
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